Chengdu Kanghong Pharmaceuticals Group Co Ltd (002773) — Cash Flow Reinvestment Rate
Chengdu Kanghong Pharmaceuticals Group Co Ltd (002773) has a Cash Flow Reinvestment Rate of 0.21x as of September 2025, reinvesting CN¥105.16 Million (capex CN¥105.16 Million ) from operating cash flow of CN¥504.02 Million. Check Chengdu Kanghong Pharmaceuticals Group C earnings quality ratio to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Chengdu Kanghong Pharmaceuticals Group Co Ltd Cash Flow Reinvestment Rate (2009–2025)
Historical reinvestment intensity for Chengdu Kanghong Pharmaceuticals Group Co Ltd across 17 annual periods. Explore Chengdu Kanghong Pharmaceuticals Group C (002773) investment intensity to see how much of total assets are deployed in long-term investments.
Annual Cash Flow Reinvestment Rate for Chengdu Kanghong Pharmaceuticals Group Co Ltd (2009–2025)
Year-by-year capital reinvestment analysis for Chengdu Kanghong Pharmaceuticals Group Co Ltd. For live market cap and broader valuation context, see market value of Chengdu Kanghong Pharmaceuticals Group C.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.20x | CN¥299.36 Million | CN¥1.50 Billion | CN¥262.48 Million | ▲ +35.7% |
| 2024 | 0.15x | CN¥207.10 Million | CN¥1.41 Billion | CN¥159.39 Million | ▲ +22.8% |
| 2023 | 0.12x | CN¥145.49 Million | CN¥1.22 Billion | CN¥138.87 Million | ▼ -80.6% |
| 2022 | 0.62x | CN¥570.76 Million | CN¥925.15 Million | CN¥355.21 Million | ▼ -62.9% |
| 2021 | 1.66x | CN¥821.27 Million | CN¥494.11 Million | CN¥569.42 Million | ▼ -27.6% |
| 2020 | 2.29x | CN¥627.07 Million | CN¥273.32 Million | CN¥617.07 Million | ▲ +66.5% |
| 2019 | 1.38x | CN¥1.12 Billion | CN¥812.15 Million | CN¥962.88 Million | ▼ -28.9% |
| 2018 | 1.94x | CN¥680.45 Million | CN¥350.88 Million | CN¥458.45 Million | ▲ +159.6% |
| 2017 | 0.75x | CN¥572.88 Million | CN¥766.86 Million | CN¥312.88 Million | ▲ +50.4% |
| 2016 | 0.50x | CN¥420.39 Million | CN¥846.35 Million | CN¥170.23 Million | ▼ -16.9% |
| 2015 | 0.60x | CN¥288.04 Million | CN¥481.97 Million | CN¥115.83 Million | ▲ +92.9% |
| 2014 | 0.31x | CN¥90.27 Million | CN¥291.38 Million | CN¥90.27 Million | ▲ +33.8% |
| 2013 | 0.23x | CN¥77.16 Million | CN¥333.31 Million | CN¥77.16 Million | ▼ -49.6% |
| 2012 | 0.46x | CN¥129.51 Million | CN¥281.84 Million | CN¥129.51 Million | ▼ -50.7% |
| 2011 | 0.93x | CN¥157.25 Million | CN¥168.86 Million | CN¥157.25 Million | ▼ -3.3% |
| 2010 | 0.96x | CN¥131.76 Million | CN¥136.79 Million | CN¥131.76 Million | ▼ -34.0% |
| 2009 | 1.46x | CN¥158.27 Million | CN¥108.42 Million | CN¥158.27 Million | — |